![[Feature Stock] HLB Pharmaceutical Confirms 1st Issuance Price for Capital Increase at 5,650 Won... Capital Increase Schedule Intensifies Ahead of Ex-Rights Trading](https://f1.tokenpost.kr/2026/08/5962eaw8mh.jpg)
Bull/Bear Index 46.0/100
→
[Feature Stock] HLB Pharmaceutical Confirms 1st Issuance Price for Capital Increase at 5,650 Won... Capital Increase Schedule Intensifies Ahead of Ex-Rights Trading
Key takeaway
"[Feature Stock] HLB Pharmaceutical Confirms 1st Issuance Price for Capital Increase at 5,650 Won... Capital Increase Schedule Intensifies Ahead of Ex-Rights Trading" — BullBear's AI rates this story as a bearish (negative) signal for markets, with a market-impact score of 50 out of 100. Reported by TokenPost on August 03, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bear flag
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 42.8%.
Join Telegram channel
or scan with phone →
